Only one small question: 90% accuracy sounds very impressive (also likely to improve over time), but is it??
study, published in the journal Nature Medicine, identified 10
molecules in blood could be used to predict with at least 90% accuracy
whether people will go on to develop mild cognitive impairment or
“The lipid panel was able to distinguish with
90% accuracy these two distinct groups: cognitively normal participants
who would progress to MCI or AD within two to three years, and those who
would remain normal in the near future,” said one of the study’s
authors, Professor Howard Federoff.
Dr Doug Brown, director of research and development at
the Alzheimer’s Society, added: “Having such a test would be an
interesting development, but it also throws up ethical considerations. “If
this does develop in the future people must be given a choice about
whether they would want to know, and fully understand the implications.